Generix Group : Poor Q1 - a release set to spell the end of the stock-market adventure
>Q1 2022-23 sales below expectations at € 20.9m, down 1.5% - Generix published yesterday evening Q1 2022-23 revenues (Q2 calendar) below our expectations. Q1 revenue came to € 20.9m (vs ODDO BHF €22.0m), down 1.5% y-o-y while we were expecting a slight increase of c. 4% over the period. This poor performance and the difference with our forecasts are mainly explained by the 46% fall in the licences segment (amplified by a base effect), the consequence of a more challen...Generix is engaged in the design and distribution of computer software. Co.'s software programs cover commercial management, accounting, production and the management of human resources.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.